Thaiss, W.; Zengerling, F.; Friedrich, J.; Hechler, V.; Grunert, M.; Bolenz, C.; Wiegel, T.; Beer, A.J.; Prasad, V.
Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre. Cancers 2023, 15, 3216.
https://doi.org/10.3390/cancers15123216
AMA Style
Thaiss W, Zengerling F, Friedrich J, Hechler V, Grunert M, Bolenz C, Wiegel T, Beer AJ, Prasad V.
Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre. Cancers. 2023; 15(12):3216.
https://doi.org/10.3390/cancers15123216
Chicago/Turabian Style
Thaiss, Wolfgang, Friedemann Zengerling, Julia Friedrich, Veronika Hechler, Michael Grunert, Christian Bolenz, Thomas Wiegel, Ambros J. Beer, and Vikas Prasad.
2023. "Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre" Cancers 15, no. 12: 3216.
https://doi.org/10.3390/cancers15123216
APA Style
Thaiss, W., Zengerling, F., Friedrich, J., Hechler, V., Grunert, M., Bolenz, C., Wiegel, T., Beer, A. J., & Prasad, V.
(2023). Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre. Cancers, 15(12), 3216.
https://doi.org/10.3390/cancers15123216